165 related articles for article (PubMed ID: 31373225)
1. Preparation, characterization and
Zare Kazemabadi F; Heydarinasab A; Akbarzadeh A; Ardjmand M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3222-3230. PubMed ID: 31373225
[No Abstract] [Full Text] [Related]
2. Efficacy of pegylated liposomal etoposide nanoparticles on breast cancer cell lines.
Mehrabi M; Esmaeilpour P; Akbarzadeh A; Saffari Z; Farahnak M; Farhangi A; Chiani M
Turk J Med Sci; 2016 Feb; 46(2):567-71. PubMed ID: 27511525
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer activity of pegylated liposomal trans-anethole on breast cancer cell lines MCF-7 and T47D.
Shahbazian S; Akbarzadeh A; Torabi S; Omidi M
Biotechnol Lett; 2015 Jul; 37(7):1355-9. PubMed ID: 25792512
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
5. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
6. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.
Poy D; Akbarzadeh A; Ebrahimi Shahmabadi H; Ebrahimifar M; Farhangi A; Farahnak Zarabi M; Akbari A; Saffari Z; Siami F
Chem Biol Drug Des; 2016 Oct; 88(4):568-73. PubMed ID: 27178305
[TBL] [Abstract][Full Text] [Related]
8. Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines.
Jinturkar KA; Anish C; Kumar MK; Bagchi T; Panda AK; Misra AR
Biomaterials; 2012 Mar; 33(8):2492-507. PubMed ID: 22200537
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity.
Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Özdemir A; Ark M; Takka S
Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327
[TBL] [Abstract][Full Text] [Related]
10. Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells.
Shahbazi R; Jafari-Gharabaghlou D; Mirjafary Z; Saeidian H; Zarghami N
Pharmacol Rep; 2023 Apr; 75(2):442-455. PubMed ID: 36859742
[TBL] [Abstract][Full Text] [Related]
11. The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin.
Shirzad M; Jamehbozorgi S; Akbarzadeh I; Aghabozorg HR; Amini A
Assay Drug Dev Technol; 2019 Jul; 17(5):231-239. PubMed ID: 31081680
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
Devrim B; Kara A; Vural İ; Bozkır A
Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
[TBL] [Abstract][Full Text] [Related]
14. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.
Khajavinia A; Varshosaz J; Dehkordi AJ
Nanotechnology; 2012 Oct; 23(40):405101. PubMed ID: 22983592
[TBL] [Abstract][Full Text] [Related]
15. Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity.
Yordanov G; Skrobanska R; Evangelatov A
Colloids Surf B Biointerfaces; 2013 Jan; 101():215-22. PubMed ID: 23010022
[TBL] [Abstract][Full Text] [Related]
16. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
17. Liposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy.
Toro-Cordova A; Flores-Cruz M; Santoyo-Salazar J; Carrillo-Nava E; Jurado R; Figueroa-Rodriguez PA; Lopez-Sanchez P; Medina LA; Garcia-Lopez P
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200551
[TBL] [Abstract][Full Text] [Related]
18. The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation
Zhang J; Liang H; Yao H; Qiu Z; Chen X; Hu X; Hu J; Zheng G
Drug Dev Ind Pharm; 2019 Jul; 45(7):1052-1060. PubMed ID: 30939950
[No Abstract] [Full Text] [Related]
19.
Dhande R; Tyagi A; Sharma RK; Thakkar H
Pulm Pharmacol Ther; 2018 Apr; 49():36-45. PubMed ID: 29337265
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Characterization and Cytotoxicity of Silibinin- Containing Nanoniosomes in T47D Human Breast Carcinoma Cells.
Amiri B; Ebrahimi-Far M; Saffari Z; Akbarzadeh A; Soleimani E; Chiani M
Asian Pac J Cancer Prev; 2016; 17(8):3835-8. PubMed ID: 27644625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]